A detailed history of Covestor LTD transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Covestor LTD holds 4 shares of SWTX stock, worth $148. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 4 -0.0%
Holding current value
$148
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$36.5 - $52.5 $36 - $52
-1 Reduced 20.0%
4 $0
Q3 2023

Nov 13, 2023

SELL
$23.12 - $31.38 $23 - $31
-1 Reduced 16.67%
5 $0
Q4 2022

Feb 13, 2023

BUY
$21.73 - $28.72 $43 - $57
2 Added 50.0%
6 $0
Q3 2022

Nov 14, 2022

SELL
$24.1 - $39.66 $24 - $39
-1 Reduced 20.0%
4 $0
Q2 2022

Aug 10, 2022

SELL
$18.36 - $60.07 $18 - $60
-1 Reduced 16.67%
5 $0
Q1 2022

May 13, 2022

SELL
$48.97 - $65.46 $97 - $130
-2 Reduced 25.0%
6 $0
Q4 2021

Feb 10, 2022

BUY
$53.3 - $75.84 $426 - $606
8 New
8 $1,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.32B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.